TLDR
- Accenture shares plummeted 18% following fiscal Q3 earnings and closed the week down approximately 25% — marking the company’s most severe weekly decline in history
- TD Cowen issued a downgrade from Buy to Hold, reducing its price target dramatically from $258 to $150
- The company reported a 3% sequential decline in bookings, with executives attributing the weakness to deals being deferred to fiscal 2027
- Both Truist and Jefferies reduced their targets, with Truist pointing to approximately $100M in revenue headwinds from Middle East geopolitical instability
- Fourteen analysts have lowered earnings projections; while no analysts have assigned a Sell rating, few identify immediate catalysts for recovery
Accenture (ACN) stock is hovering around the $120–$123 range Monday, continuing last week’s devastating decline that erased nearly 25% of its market value — representing the consulting giant’s worst weekly showing since going public.
The downturn commenced Thursday when shares tumbled 18% to $127.98 following the release of fiscal third-quarter results. The company reported revenue of $18.7 billion, marginally below analyst expectations of $18.78 billion, though adjusted earnings per share of $3.80 exceeded the $3.72 consensus estimate. Despite beating on the bottom line, the earnings surprise couldn’t overcome concerns about disappointing guidance and a 3% sequential contraction in new bookings.
TD Cowen’s Bryan Bergin spearheaded Monday’s wave of downgrades, shifting his rating on ACN from Buy to Hold while slashing his price objective to $150 from $258.
“Our thesis around near-term stability followed by potential recovery proved incorrect,” Bergin acknowledged. He explained that maintaining an optimistic stance lacked justification “given the deteriorating fundamentals.”
The bookings disappointment emerged as the primary concern. Bergin noted the 3% contraction “caught us completely off guard” — his model had anticipated at least moderate expansion.
Company leadership attributed the shortfall to several substantial contracts being delayed into fiscal 2027. However, Bergin pointed out that even accounting for a hypothetical $1 billion timing shift, managed services bookings would still show negative growth — a scenario that would have disappointed investors under any circumstances.
Wall Street Slashes Price Expectations
Truist Securities reduced its target from $210 to $150 while maintaining a Hold stance. The firm identified approximately $100 million in revenue exposure linked to Middle East geopolitical tensions, with impacts anticipated to persist through the fourth quarter and possibly longer.
Truist had previously downgraded ACN several weeks ago, highlighting constrained client budgets, AI-related revenue displacement, and geopolitical uncertainty. Secondary effects from the Iran situation began materializing in the closing weeks of Q3, and the firm anticipates prolonged decision-making timelines going forward.
Jefferies analyst Surinder Thind similarly trimmed his price objective, bringing it down to $130 from $185 while retaining his Hold rating. He had identified softening demand trends dating back to March. Thind referenced reduced revenue and earnings forecasts for calendar year 2027 and noted that geopolitical headwinds are compounding already tepid discretionary technology spending.
RBC Capital lowered its target to $175 from $253. Guggenheim adjusted downward to $185 from $225 while maintaining a Buy recommendation.
Current Analyst Sentiment
Among 30 firms monitored by FactSet, 17 assign ACN a Buy or Overweight rating. The other 13 classify it as Hold. Notably, no analyst presently rates the stock as a Sell.
Nevertheless, 14 analysts have revised earnings expectations downward for the forthcoming period, according to InvestingPro data. Shares are trading close to the 52-week low of $125.60, and technical indicators including the RSI suggest the stock has entered oversold conditions.
Chief Executive Julie Sweet identified Middle East tensions as a contributing factor to quarterly underperformance. The organization has simultaneously pursued an aggressive M&A strategy focused on cybersecurity capabilities and established strategic partnerships with OpenAI and Anthropic to develop agentic AI solutions.
ACN stock was changing hands at $120.85 Monday afternoon, declining approximately 5.6% during the session.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
